ozempic semaglutide patent expiry Growing concerns over weight loss drugs as patents set to expire ICYMI: Shortly after Novo Nordisk's

Duodenal switch, makes GLP-1 go way up, and since food skips the part of the intestine where GIP is made, like bypass, GIP is reduced

The upper arm falls somewhere in between but is harder to self-inject without assistance

At 6 months, 68% had returned to weekly dosing, citing no perceived benefit and increased hassle

At InfusaLounge Integrative & Functional Medicine in Allen, Texas, we use semaglutide as part of a personalized, medically supervised program that supports your metabolism, hormones, and overall healthnot just the number on the scale

FIGURE 5 An additional consideration relates to the nature of comparator arms in the included trials

So far, clinical trials suggest that people taking retatrutide may experience greater overall weight loss than what has been seen with earlier GLP-1 medications